Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
VentriPoint Diagnostics Ltd
V.VPT
Alternate Symbol(s):
VPTDF
Technology
Scientific & Technical Instruments
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and...
cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSXV:VPT - Post Discussion
VentriPoint Diagnostics Ltd
> 🔬 A New Era in TAVR Starts Here !
New Post
View:
Discussion
List
(34)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Dec 20, 2024 9:50am
🔬 A New Era in TAVR Starts Here !
Interesting remember Hugh call on Angiopro,
9 Dec 2024 interesting see AngioPro & Hugh
9 Dec 2024
call: Similarly, we worked with AngioPro to conduct demonstrations at a number of sites in Europe
....& comment Bart
Post Angiopro and See Bart comment on post SassyWire
Interesting and remember post (
Bart Hendrikx
on
#
SavvyWire
is the first and only sensor-guided solution designed specifically to optimize TAVR
.)
Bart Hendriks
aime ceci
Angiopro GmbH
Angiopro GmbH
2052 abonns
2052 abonns
2 h •
Il y a 2 heures
SavvyWire: Innovation You Can Trust
Angiopro GmbH
Angiopro GmbH
2060 abonns
2060 abonns
4 h •
Il y a 4 heures
A New Era in TAVR Starts Here
With the
hashtag
#
SavvyWire
pre-shaped pressure guidewire, you get:
Enhanced procedural stability
The power of the Fidela Fiber Optic Sensors
Seamless data integration for better decision-making
The future of TAVR is all about smarter, simpler, and safer procedures—and SavvyWire delivers on all fronts.
https://lnkd.in/eFuxv6yZ
hashtag
#
SavvyWire
hashtag
#
TAVRInnovation
hashtag
#
Hemodynamics
hashtag
#
HealthcareInnovation
Afficher la traduction
Activez pour voir l’image en plus grand.
(34)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Dec 20, 2024 8:07pm
GranhamF... ( You really got it in for Ventripoint. The only conclusion I can make of your disdain for it is that you must have dropped a bundle on it years back and it's your mission to see it fail. ) GranhamF the vulture is perched. For all new people watching Ventripoint it is important to know about GranhamF. He is a manipulative vulture with several fake accounts here and on ceo
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments